● Sulfacetamide sodium (N-sulfanilylacetamide monosodium salt monohydrate) is a sulfonamide antibacterial agent; sulfonamides are bacteriost
● Sulfacetamide sodium (N-sulfanilylacetamide monosodium salt monohydrate) is a sulfonamide antibacterial agent; sulfonamides are bacteriostatic [1][3]
● Inhibits bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with aminobenzoic acid through competitive inhibition of the enzyme dihydropteroate synthetase [1]
● Active against susceptible strains of Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus influenzae, Klebsiella species and Enterobacter species [1]
● Does not provide adequate coverage against Neisseria species, Serratia marcescens and Pseudomonas aeruginosa; a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs [1]
● Sterile ophthalmic solution, sulfacetamide sodium 15% (150 mg/mL), in 0.4 mL single-dose units [1][2]
| Product Name | Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL |
|---|---|
| Dosage Form | Ophthalmic |
| Strength | 15% (150 mg/mL) 0.4 mL |
| Standards | BP / ENTERPRISE |
| Packing | 10 pics/box |
| Documents | COA, COPP, DMF, CTD Dossiers |
| MOQ | Contact us for MOQ and current stock |
Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.
Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.
Full batch testing and quality traceability under standard GMP workshops.
Sufficient stock on regular items, familiar with export logistics to 50+ countries.
COA, DMF, dossier and legalization documents for your market registration.
Every batch of Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.
MOQ and lead time for Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.
Yes. We offer OEM packaging and private-label production for Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL, subject to the regulatory requirements of the destination market.
We have supplied ophthalmic products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.
Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.